Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer. - Park YH; Im SA; Park K; Wen J; Lee KH; Choi YL; Lee WC; Min A; Bonato V; Park S; Ram S; Lee DW; et al. (Genome medicine, 2023)